[ad_1] Introduction I hope that everyone reading this has a baseline knowledge of Amarin (AMRN), its sole product Vascepa, and the REDUCE-IT cardiovascular outcomes trial, or CVOT. Further, presumably everyone is aware …
Read More »Amarin’s REDUCE-IT Trial: Something Fishy? – Amarin Corporation PLC (NASDAQ:AMRN)
